Global Sarcopenia Healthcare Market Research Report 2023

December 2023 | 90 pages | ID: GF132D1BC11AEN
QYResearch

Abstracts

Research is now focusing on the role of physical activity, nutrition, and potential future medications that may be used to treat or prevent sarcopenia.

According to QYResearch’s new survey, global Sarcopenia Healthcare market is projected to reach US$ 3670 million in 2029, increasing from US$ 2762.8 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sarcopenia Healthcare market research.

Key companies engaged in the Sarcopenia Healthcare industry include Abbott Laboratories, Nestlй, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline and Bayer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Sarcopenia Healthcare were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sarcopenia Healthcare market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sarcopenia Healthcare market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• Abbott Laboratories
• Nestlй
• Pfizer
• Amway
• By-health
• Usana
• A&Z Pharmaceutical
• GlaxoSmithKline
• Bayer
• H&H
• Blackmores
• Zhendong Group

Segment by Type

• Protein Supplement
• Calcium Supplement
• Other

Segment by Application

• Online Pharmacies
• Retail Pharmacies

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

The Sarcopenia Healthcare report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Sarcopenia Healthcare Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Protein Supplement
  1.2.3 Calcium Supplement
  1.2.4 Other
1.3 Market by Application
  1.3.1 Global Sarcopenia Healthcare Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Online Pharmacies
  1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Sarcopenia Healthcare Market Perspective (2018-2029)
2.2 Sarcopenia Healthcare Growth Trends by Region
  2.2.1 Global Sarcopenia Healthcare Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Sarcopenia Healthcare Historic Market Size by Region (2018-2023)
  2.2.3 Sarcopenia Healthcare Forecasted Market Size by Region (2024-2029)
2.3 Sarcopenia Healthcare Market Dynamics
  2.3.1 Sarcopenia Healthcare Industry Trends
  2.3.2 Sarcopenia Healthcare Market Drivers
  2.3.3 Sarcopenia Healthcare Market Challenges
  2.3.4 Sarcopenia Healthcare Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Sarcopenia Healthcare Players by Revenue
  3.1.1 Global Top Sarcopenia Healthcare Players by Revenue (2018-2023)
  3.1.2 Global Sarcopenia Healthcare Revenue Market Share by Players (2018-2023)
3.2 Global Sarcopenia Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sarcopenia Healthcare Revenue
3.4 Global Sarcopenia Healthcare Market Concentration Ratio
  3.4.1 Global Sarcopenia Healthcare Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Sarcopenia Healthcare Revenue in 2022
3.5 Sarcopenia Healthcare Key Players Head office and Area Served
3.6 Key Players Sarcopenia Healthcare Product Solution and Service
3.7 Date of Enter into Sarcopenia Healthcare Market
3.8 Mergers & Acquisitions, Expansion Plans

4 SARCOPENIA HEALTHCARE BREAKDOWN DATA BY TYPE

4.1 Global Sarcopenia Healthcare Historic Market Size by Type (2018-2023)
4.2 Global Sarcopenia Healthcare Forecasted Market Size by Type (2024-2029)

5 SARCOPENIA HEALTHCARE BREAKDOWN DATA BY APPLICATION

5.1 Global Sarcopenia Healthcare Historic Market Size by Application (2018-2023)
5.2 Global Sarcopenia Healthcare Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Sarcopenia Healthcare Market Size (2018-2029)
6.2 North America Sarcopenia Healthcare Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sarcopenia Healthcare Market Size by Country (2018-2023)
6.4 North America Sarcopenia Healthcare Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Sarcopenia Healthcare Market Size (2018-2029)
7.2 Europe Sarcopenia Healthcare Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sarcopenia Healthcare Market Size by Country (2018-2023)
7.4 Europe Sarcopenia Healthcare Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Sarcopenia Healthcare Market Size (2018-2029)
8.2 Asia-Pacific Sarcopenia Healthcare Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sarcopenia Healthcare Market Size by Region (2018-2023)
8.4 Asia-Pacific Sarcopenia Healthcare Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Sarcopenia Healthcare Market Size (2018-2029)
9.2 Latin America Sarcopenia Healthcare Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sarcopenia Healthcare Market Size by Country (2018-2023)
9.4 Latin America Sarcopenia Healthcare Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Sarcopenia Healthcare Market Size (2018-2029)
10.2 Middle East & Africa Sarcopenia Healthcare Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sarcopenia Healthcare Market Size by Country (2018-2023)
10.4 Middle East & Africa Sarcopenia Healthcare Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Detail
  11.1.2 Abbott Laboratories Business Overview
  11.1.3 Abbott Laboratories Sarcopenia Healthcare Introduction
  11.1.4 Abbott Laboratories Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.1.5 Abbott Laboratories Recent Development
11.2 Nestlй
  11.2.1 Nestlй Company Detail
  11.2.2 Nestlй Business Overview
  11.2.3 Nestlй Sarcopenia Healthcare Introduction
  11.2.4 Nestlй Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.2.5 Nestlй Recent Development
11.3 Pfizer
  11.3.1 Pfizer Company Detail
  11.3.2 Pfizer Business Overview
  11.3.3 Pfizer Sarcopenia Healthcare Introduction
  11.3.4 Pfizer Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.3.5 Pfizer Recent Development
11.4 Amway
  11.4.1 Amway Company Detail
  11.4.2 Amway Business Overview
  11.4.3 Amway Sarcopenia Healthcare Introduction
  11.4.4 Amway Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.4.5 Amway Recent Development
11.5 By-health
  11.5.1 By-health Company Detail
  11.5.2 By-health Business Overview
  11.5.3 By-health Sarcopenia Healthcare Introduction
  11.5.4 By-health Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.5.5 By-health Recent Development
11.6 Usana
  11.6.1 Usana Company Detail
  11.6.2 Usana Business Overview
  11.6.3 Usana Sarcopenia Healthcare Introduction
  11.6.4 Usana Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.6.5 Usana Recent Development
11.7 A&Z Pharmaceutical
  11.7.1 A&Z Pharmaceutical Company Detail
  11.7.2 A&Z Pharmaceutical Business Overview
  11.7.3 A&Z Pharmaceutical Sarcopenia Healthcare Introduction
  11.7.4 A&Z Pharmaceutical Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.7.5 A&Z Pharmaceutical Recent Development
11.8 GlaxoSmithKline
  11.8.1 GlaxoSmithKline Company Detail
  11.8.2 GlaxoSmithKline Business Overview
  11.8.3 GlaxoSmithKline Sarcopenia Healthcare Introduction
  11.8.4 GlaxoSmithKline Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
  11.9.1 Bayer Company Detail
  11.9.2 Bayer Business Overview
  11.9.3 Bayer Sarcopenia Healthcare Introduction
  11.9.4 Bayer Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.9.5 Bayer Recent Development
11.10 H&H
  11.10.1 H&H Company Detail
  11.10.2 H&H Business Overview
  11.10.3 H&H Sarcopenia Healthcare Introduction
  11.10.4 H&H Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.10.5 H&H Recent Development
11.11 Blackmores
  11.11.1 Blackmores Company Detail
  11.11.2 Blackmores Business Overview
  11.11.3 Blackmores Sarcopenia Healthcare Introduction
  11.11.4 Blackmores Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.11.5 Blackmores Recent Development
11.12 Zhendong Group
  11.12.1 Zhendong Group Company Detail
  11.12.2 Zhendong Group Business Overview
  11.12.3 Zhendong Group Sarcopenia Healthcare Introduction
  11.12.4 Zhendong Group Revenue in Sarcopenia Healthcare Business (2018-2023)
  11.12.5 Zhendong Group Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Sarcopenia Healthcare Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Protein Supplement
Table 3. Key Players of Calcium Supplement
Table 4. Key Players of Other
Table 5. Global Sarcopenia Healthcare Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Sarcopenia Healthcare Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Sarcopenia Healthcare Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sarcopenia Healthcare Market Share by Region (2018-2023)
Table 9. Global Sarcopenia Healthcare Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Sarcopenia Healthcare Market Share by Region (2024-2029)
Table 11. Sarcopenia Healthcare Market Trends
Table 12. Sarcopenia Healthcare Market Drivers
Table 13. Sarcopenia Healthcare Market Challenges
Table 14. Sarcopenia Healthcare Market Restraints
Table 15. Global Sarcopenia Healthcare Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sarcopenia Healthcare Market Share by Players (2018-2023)
Table 17. Global Top Sarcopenia Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Healthcare as of 2022)
Table 18. Ranking of Global Top Sarcopenia Healthcare Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sarcopenia Healthcare Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sarcopenia Healthcare Product Solution and Service
Table 22. Date of Enter into Sarcopenia Healthcare Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sarcopenia Healthcare Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sarcopenia Healthcare Revenue Market Share by Type (2018-2023)
Table 26. Global Sarcopenia Healthcare Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Sarcopenia Healthcare Revenue Market Share by Type (2024-2029)
Table 28. Global Sarcopenia Healthcare Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sarcopenia Healthcare Revenue Market Share by Application (2018-2023)
Table 30. Global Sarcopenia Healthcare Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Sarcopenia Healthcare Revenue Market Share by Application (2024-2029)
Table 32. North America Sarcopenia Healthcare Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Sarcopenia Healthcare Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sarcopenia Healthcare Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Sarcopenia Healthcare Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Sarcopenia Healthcare Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Sarcopenia Healthcare Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Sarcopenia Healthcare Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Sarcopenia Healthcare Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Sarcopenia Healthcare Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Sarcopenia Healthcare Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Sarcopenia Healthcare Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Sarcopenia Healthcare Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Sarcopenia Healthcare Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Sarcopenia Healthcare Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Sarcopenia Healthcare Market Size by Country (2024-2029) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Sarcopenia Healthcare Product
Table 50. Abbott Laboratories Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Nestlй Company Detail
Table 53. Nestlй Business Overview
Table 54. Nestlй Sarcopenia Healthcare Product
Table 55. Nestlй Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 56. Nestlй Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Sarcopenia Healthcare Product
Table 60. Pfizer Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Amway Company Detail
Table 63. Amway Business Overview
Table 64. Amway Sarcopenia Healthcare Product
Table 65. Amway Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 66. Amway Recent Development
Table 67. By-health Company Detail
Table 68. By-health Business Overview
Table 69. By-health Sarcopenia Healthcare Product
Table 70. By-health Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 71. By-health Recent Development
Table 72. Usana Company Detail
Table 73. Usana Business Overview
Table 74. Usana Sarcopenia Healthcare Product
Table 75. Usana Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 76. Usana Recent Development
Table 77. A&Z Pharmaceutical Company Detail
Table 78. A&Z Pharmaceutical Business Overview
Table 79. A&Z Pharmaceutical Sarcopenia Healthcare Product
Table 80. A&Z Pharmaceutical Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 81. A&Z Pharmaceutical Recent Development
Table 82. GlaxoSmithKline Company Detail
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Sarcopenia Healthcare Product
Table 85. GlaxoSmithKline Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Sarcopenia Healthcare Product
Table 90. Bayer Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. H&H Company Detail
Table 93. H&H Business Overview
Table 94. H&H Sarcopenia Healthcare Product
Table 95. H&H Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 96. H&H Recent Development
Table 97. Blackmores Company Detail
Table 98. Blackmores Business Overview
Table 99. Blackmores Sarcopenia Healthcare Product
Table 100. Blackmores Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 101. Blackmores Recent Development
Table 102. Zhendong Group Company Detail
Table 103. Zhendong Group Business Overview
Table 104. Zhendong Group Sarcopenia Healthcare Product
Table 105. Zhendong Group Revenue in Sarcopenia Healthcare Business (2018-2023) & (US$ Million)
Table 106. Zhendong Group Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Sarcopenia Healthcare Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Sarcopenia Healthcare Market Share by Type: 2022 VS 2029
Figure 3. Protein Supplement Features
Figure 4. Calcium Supplement Features
Figure 5. Other Features
Figure 6. Global Sarcopenia Healthcare Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Sarcopenia Healthcare Market Share by Application: 2022 VS 2029
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Sarcopenia Healthcare Report Years Considered
Figure 11. Global Sarcopenia Healthcare Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Sarcopenia Healthcare Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sarcopenia Healthcare Market Share by Region: 2022 VS 2029
Figure 14. Global Sarcopenia Healthcare Market Share by Players in 2022
Figure 15. Global Top Sarcopenia Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Healthcare as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Sarcopenia Healthcare Revenue in 2022
Figure 17. North America Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Sarcopenia Healthcare Market Share by Country (2018-2029)
Figure 19. United States Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Sarcopenia Healthcare Market Share by Country (2018-2029)
Figure 23. Germany Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Sarcopenia Healthcare Market Share by Region (2018-2029)
Figure 31. China Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Sarcopenia Healthcare Market Share by Country (2018-2029)
Figure 39. Mexico Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Sarcopenia Healthcare Market Share by Country (2018-2029)
Figure 43. Turkey Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Sarcopenia Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 46. Nestlй Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 48. Amway Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 49. By-health Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 50. Usana Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 51. A&Z Pharmaceutical Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 54. H&H Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 55. Blackmores Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 56. Zhendong Group Revenue Growth Rate in Sarcopenia Healthcare Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed